Guobang Pharma Ltd.
public_traded
Guobang Pharma Ltd. is publicly traded on SHH under ticker 605507.SS.
Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations. The company was founded in 1996 and is based in Xinchang, China.